ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Biomimetic erythrocytes engineered drug delivery for cancer therapy

Zhang, Wenyuan; Zhao, Man; Gao, Yali; Cheng, Xu; Liu, Xiaoying; Tang, Shukun; Peng, Yanbo; Wang, Na; Hu, Dandan; Peng, Haisheng*; Zhang, Jinqiu*; Wang, Qun*哈尔滨医科大学; 1
Chemical Engineering Journal2022-4-1DOI: 10.1016/j.cej.2021.133498
18被引4阅读
引用收藏
分享

摘要

Cancer is a significant cause of high mortality, while the adverse reactions caused by traditional chemotherapy inevitably further increase the mortality rate. Although synthetic nanocarriers (NCs) have been applied for cancer treatment, the exogenous particles are usually removed rapidly by the reticuloendothelial system (RES). Taking inspiration from nature, a "camouflage" with red blood cell membranes (RBCMs) makes biomimetic NCs a new research hotspot that attracts more and more researchers' attention. Using this bionic method, the NCs achieve "stealthy effects" in vivo by separating the particle from the surrounding environment by the RBCMs, thus avoiding the identification of macrophages to acquire a longer half-life time of particles in the blood vessel. Here, we only focus on studying biomimetic drug delivery systems based on engineered erythrocytes. The live erythrocyte, nanoscale vesicles of RBCMs, and NCs coated with RBCMs or hybrid membrane, including RBCMs engineering and preparation, drug loading, escape mechanisms, and core-shell structure, have been discussed. The biomimetic strategies of nanoparticles coating with RBCMs in tumor therapy have been further highlighted.

学科与关键词

关键词
ErythrocytesBiomimeticNanocarriersDrug DeliveryCancer
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Chemical Engineering Journal
发表日期
2022-04-01
卷期
第 433 卷
页码
133498
DOI
10.1016/j.cej.2021.133498
语言
MULTI-LANGUAGE
期刊等级
1区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81671814]; Heilongjiang Provincial Nat-ural Science Foundation [ZD2016013]; Training Project of Translation Medicine from Technology Innovation Center for Accurate Diagnosis and Treatment of Cold Land Diseases in Heilongjiang Province [CXZX-ZXKT02, CXZX-ZXKT03]; Fundamental Research Funds for the Provincial Universities [JFWLD202002, 2018XN-22, 2018XN-24, JFXN201902, JFXN201908]; Guiding project of Science andTechnology from Science and Technology Bureau of Daqing City [zdy-2019-87, zdy-2019-88]; PhRMA Foundation Research Starter Award [RSGTMT17]

作者

  • Z

    Zhang, Wenyuan (第一作者)

    1 · harbin med univ

  • Z

    Zhao, Man

    1 · harbin med univ

查看全部 12 位作者收起作者
  • G

    Gao, Yali

    1 · harbin med univ

  • C

    Cheng, Xu

    1 · harbin med univ

  • L

    Liu, Xiaoying

    1 · harbin med univ

  • T

    Tang, Shukun

    1 · harbin med univ

  • P

    Peng, Yanbo

    china pharmaceut univ

  • W

    Wang, Na

    1 · harbin med univ

  • H

    Hu, Dandan

    1 · harbin med univ

  • P

    Peng, Haisheng (通讯)

    1 · harbin med univ

  • Z

    Zhang, Jinqiu (通讯)

    daqing normal univ

  • W

    Wang, Qun (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417